MALAT1 accelerates the development and progression of renal cell carcinoma by decreasing the expression of miR‐203 and promoting the expression of BIRC5
Author:
Affiliation:
1. Department of Urology, Shanghai Tenth People’s Hospital Tongji University School of Medicine Shanghai China
2. Department of Urology, Shanghai General Hospital The First People's Hospital Affiliated to Shanghai Jiaotong University Shanghai China
Funder
Shanghai Municipal Health and Family Planning Commission
Publisher
Wiley
Subject
Cell Biology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.12640
Reference40 articles.
1. miRNA-34a Suppresses Cell Proliferation and Metastasis by Targeting CD44 in Human Renal Carcinoma Cells
2. Characterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencing
3. MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma
4. Epidemiology of renal cancer in developing countries: Review of the literature;Medina‐Rico M;Can Urol Assoc J,2018
5. High expression of long non‐coding RNA SPRY4‐IT1 predicts poor prognosis of clear cell renal cell carcinoma;Zhang HM;Int J Clin Exp Pathol,2014
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exosomes as novel tools for renal cell carcinoma therapy, diagnosis, and prognosis;Heliyon;2024-06
2. Beyond the genome: MALAT1's role in advancing urologic cancer care;Pathology - Research and Practice;2024-04
3. Optimized reconstruction of the absorption spectra of kidney tissues from the spectra of tissue components using the least squares method;Journal of Biophotonics;2024-02-06
4. A two-layer circuit cascade-based DNA machine for highly sensitive miRNA imaging in living cells;The Analyst;2024
5. The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma;BMC Nephrology;2023-12-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3